For lovers of Dragons, art and story.
On the trail of dragons forgotten, an intrepid illustrator and reporter journeys from Europe through the Middle East and finally to Saigon in search of the dark caverns and mountaintop perches where the elusive winged serpents dwell. With the gift of seeing the invisible, our explorer friend records each encounter in a journal of gorgeous, fully painted artwork, capturing every majestic and fearsome visual detail of the scaly behemoths, and accompanies his findings with snippets of local lore as evidence that these hidden beasts continue to shape the world in ways we may never expect! Find out more here- http://www.dynamite.com/htmlfiles/viewProduct.html?PRO=C1606904647 Use #Lost Dragons on Twitter for a chance to win the book!
Brought to you by Dynamite Entertainment! Video by Arsenic et Boule de Gomme. Book by Elian Black'Mor, Carine-M, Jezequel. Fantasy/Comics/Graphic novel
Ahead of World Mental Health Day, today sees the publication of the Mental Health Integration Index, a new research initiative commissioned by the Janssen Pharmaceutical Companies of Johnson & Johnson and undertaken by the Economist Intelligence Unit.1 The research explores the challenges of integrating Europeans with mental illness into society and employment, within the European Union’s 28 Member States, plus Norway and Switzerland. Countries have been ranked according to their degree of commitment to support those living with mental illness; the findings demonstrate that while there are many examples of good practice across Europe, the whole region has a long way to go before people with mental illness are adequately supported and truly integrated into their communities.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/72762557-janssen-europe-mental-health-index/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Douwe Geluk is a Tai Chi master from Apeldoorn city inthe Netherlands. He participated in a bigg martial arts tournament in Brussels, Bruxelles Belgium. It was organised by Said Belabed a student of World Famous Chiu Chi Ling a Hung Gar master en movie star. In this video you see Douwe Geluk his martial arts moves in action at the tournament
It's longer – and deeper – than any other train tunnel in the world. Sunday 11 December 2016 sees the entering into service of the Gotthard Base Tunnel. This pioneering project will enable passengers to speed under the Alps in some 17 minutes. The dual-track tunnel will bring northern and southern Switzerland closer together, and cut travel time between neighbouring countries. It will permit passengers from near and far to spend more time at their destination, discovering the many delights of Switzerland north and south of the Alps.
Switzerland already possesses the densest public transport network on the planet. And over the years it has increased its impressive lead over other nations. June 2016 saw the festive inauguration of the Gotthard Base Tunnel – a 17-year pioneering project which extends for 57 kilometres down to a maximum depth of 2300 metres under the Gotthard massif. The Swiss Federal Railways (SBB) have now finished subjecting the tunnel to exhaustive safety and technical tests. On Sunday 11 December – the day on which Switzerland's public transport network changes its annual timetable nationwide – the Gotthard Base Tunnel will enter into scheduled service.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7988951-opening-gotthard-base-tunnel-longest-train/
INRIX®, Inc., a global leader for transportation analytics, today released its 2015 Traffic Scorecard, a benchmark for governments and agencies in the U.S. and Europe to measure progress in improving urban mobility.
The report reveals the U.S. faces large challenges to solve congestion issues, fueled by continued economic and population growth, higher employment rates and declining gas prices. Cities that have experienced the most economic improvement during the past year are at highest risk for consequences related to worsened traffic conditions, including reduced productivity, higher emissions and increased stress levels. For example, Washington D.C., San Francisco, New York, Seattle and Boston all saw reduced unemployment rates bringing them below the national average of 5.3 percent for 2015.1 However, according to the INRIX Traffic Scorecard, congestion in those cities alone combined to waste 1.5 billion hours for daily car commuters last year. Nationwide, commuters spent a total of more than eight billion extra hours stuck in traffic, representing almost 50 hours per driver.
To view the multimedia release go to:
http://www.multivu.com/players/English/7775551-inrix-2015-traffic-scorecard/
Asendia, the joint venture between La Poste and Swiss Post, regularly produces insights on the burgeoning e-commerce market and the very exciting opportunities it is offering to online retailers who would like to take their business global.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/72762578-asendia-e-commerce-trends-insight/
Galderma, a leading global pharmaceutical company exclusively focused on dermatology, today announced that the European Commission has granted Marketing Authorisation in Europe for Mirvaso® (brimonidine) 3 mg/g gel.
Mirvaso® is an alpha-2 adrenergic receptor agonist that acts rapidly and can last for up to 12 hours.1 It is indicated for the symptomatic treatment of facial erythema (redness) of rosacea in adult patients.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65011-mirvaso-first-and-only-treatment-rosacea
Douwe Geluk a well known Dutch master of the Chinese martial arts participated at the Golden Bridge martial arts tournament 2019 in Lelystad city in the Netherlands.
This event was hosted and organised by sifu Mark de Haan of the KFVN Kungfu Vereniging Nederland.
Douwe Geluk from Apeldoorn city particpated with Taijiquan, Tai Chi Chuan also known as Tai Ji and won two golden medals at this Dutch event.
Ana Schmidt has been announced as the winner of the 2018 Columbia Threadneedle Prize, Europe’s leading open competition for figurative and representational art, which is celebrating its 10th anniversary this year. Ana receives a cash prize of £20,000 and a solo exhibition for a wider body of work in the Threadneedle Space at Mall Galleries.
Ana Schmidt is a 'realist' painter based in Bilbao, where she works as an urban planning architect and figurative painter. Her work focuses on depictions of urban landscapes and how they appear in our everyday experience. Finding inspiration from her immediate surroundings, Ana is especially interested in painting the territorial changes brought on over the last decades by the process of urban transformation and sprawl.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8264051-winner-2018-columbia-threadneedle/
Although the NHS is ranked as one of the institutions that makes people ‘most proud to be British’1, a new poll commissioned by Astellas Pharma Europe Ltd, highlights that 91% of people feel that the health service is in need of change2. In particular, shorter waiting times (36% of respondents) and improved access to medicines (30%) rank most highly as the areas in need of greatest reform.
With only 1 in 4 of respondents agreeing that the Government currently spends enough on health, the survey reveals that those polled would be willing to accept an average charge of £10 for a missed GP appointment in order to improve service levels. The people polled also said they would be willing to pay an average of £170 per year in additional income tax for healthcare funding – which could result in approximately £5 billion in additional tax revenue for the Treasury3. In addition to these charges, 39% of those polled would be willing to accept an additional charge if it meant quicker access to healthcare services and 44% of those polled would be willing to accept additional charges if it meant access to newer and potentially more effective medicines.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7753151-astellas-survey-public-support-nhs-concern/
